Xtant Medical Set to Showcase Innovations at 2026 Musculoskeletal Conference in New Orleans

Xtant Medical Positions for Leadership in Surgical Solutions at Upcoming Conference

Xtant Medical Holdings, Inc. stands on the threshold of an important moment as it announces the participation of its executive team in the Canaccord Genuity 2026 Musculoskeletal Conference. Scheduled for March 2, 2026, in New Orleans, the event will highlight the company's significant contributions to medical technologies for spinal, orthopedic, and wound care disorders. With CEO Sean Browne, CFO Scott Neils, and COO Mark Schallenberger in attendance, Xtant Medical aims to further establish its dedication to improving patient outcomes through innovative solutions. This conference not only offers insights into the company’s strategic direction but also positions Xtant Medical as a thought leader within the competitive landscape of medical technology.

In addition to attending the conference, Xtant Medical provides an opportunity for wider engagement through the virtual accessibility of its presentation. A live webcast is set to commence on February 2, 2026, allowing stakeholders and interested parties to gain valuable insights directly from the executive team. After the conference concludes, the company plans to make a replay of the presentation available on its investor relations website for 90 days, ensuring that information about its cutting-edge products and strategic initiatives reaches a broad audience. This accessibility underscores Xtant Medical's commitment to transparency and proactive communication with its stakeholders.

Xtant Medical is dedicated to upholding its mission to honor the gift of donation and enhance patients’ quality of life. The company emphasizes the importance of a robust product portfolio that includes orthobiologics for chronic wound care and sports medicine, in addition to advanced spinal implant systems. With a focus on serving their customers effectively and maintaining high integrity, Xtant Medical's workforce reflects its values and commitment to the healthcare sector. The legitimacy and proprietary nature of its technologies and products are further reinforced by the acknowledgment of its trademarks, highlighting its competitive edge in the field.

In summary, Xtant Medical is poised to leverage the upcoming Canaccord Genuity conference to not only share its advancements and innovations but also strengthen its position in the medical technology arena. As the company continues to innovate and focus on patient outcomes, its participation in such key industry events highlights its active role in shaping the future of surgical solutions. The commitment to transparency and engagement further enhances its reputation as a forward-thinking leader in the medical community.